News
One of the foremost hurdles encountered in the pursuit of weight loss is the apprehension of physical exhaustion and the ...
Gluco Armor’s Liquid Formula Emerges as a Natural, Science-Backed Solution for Blood Sugar Support, Offering a Functional ...
Growth through acquisition has been an attractive option for many organizations in the pharma cold chain. One recent example ...
Aurora Cannabis Inc. , the Canadian-based leading global medical cannabis company, has announced today the availability of medical cannabis concentrates to patients in the United Kingdom (UK). This ...
India’s first specialty pharma pure-play CDMO business, on Thursday announced that its flagship Unit 2 facility in Bengaluru has been granted Good Manufacturing Practices (GMP) certification by ANVISA ...
Granules India has completed its acquisition of Senn Chemicals AG, a Switzerland-based contract development and manufacturing ...
OneSource’s unit 2 facility in Bengaluru gets Brazilian Health Regulatory Agency approval: Our Bureau, Mumbai Thursday, April 10, 2025, 15:50 Hrs [IST] OneSource Specialty Pharm ...
OneSource Specialty Pharma on Thursday said its flagship unit has received approval from the Brazillian health authority ANVISA. The company's Unit 2 facility in Bengaluru has been granted Good ...
OneSource Specialty Pharma's Unit 2 in Bengaluru receives GMP certification from ANVISA, enabling the company to supply ...
Baar, 9 April 2025 – PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced that the shareholders approved all proposals put ...
Giulio Cossu, MD, University of Manchester, discusses barriers to gene therapy research and development.
ERBC & Menarini Biotech join forces to speed up development of biopharmaceuticals from research to first-in-human clinical trials: Baugy, France Monday, April 7, 2025, 13:00 Hrs [ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results